756 related articles for article (PubMed ID: 25874605)
21. Interaction between coxsackievirus B3 infection and α-synuclein in models of Parkinson's disease.
Park SJ; Jin U; Park SM
PLoS Pathog; 2021 Oct; 17(10):e1010018. PubMed ID: 34695168
[TBL] [Abstract][Full Text] [Related]
22. The misfolding mystery: α-synuclein and the pathogenesis of Parkinson's disease.
Negi S; Khurana N; Duggal N
Neurochem Int; 2024 Jul; 177():105760. PubMed ID: 38723900
[TBL] [Abstract][Full Text] [Related]
23. Molecular chaperones and associated cellular clearance mechanisms against toxic protein conformers in Parkinson's disease.
Hinault MP; Farina-Henriquez-Cuendet A; Goloubinoff P
Neurodegener Dis; 2011; 8(6):397-412. PubMed ID: 21411979
[TBL] [Abstract][Full Text] [Related]
24. Bent out of shape: α-Synuclein misfolding and the convergence of pathogenic pathways in Parkinson's disease.
Luna E; Luk KC
FEBS Lett; 2015 Dec; 589(24 Pt A):3749-59. PubMed ID: 26505673
[TBL] [Abstract][Full Text] [Related]
25. Identification of a highly neurotoxic α-synuclein species inducing mitochondrial damage and mitophagy in Parkinson's disease.
Grassi D; Howard S; Zhou M; Diaz-Perez N; Urban NT; Guerrero-Given D; Kamasawa N; Volpicelli-Daley LA; LoGrasso P; Lasmézas CI
Proc Natl Acad Sci U S A; 2018 Mar; 115(11):E2634-E2643. PubMed ID: 29487216
[TBL] [Abstract][Full Text] [Related]
26. α-Synuclein in Parkinson's Disease: Does a Prion-Like Mechanism of Propagation from Periphery to the Brain Play a Role?
Zheng H; Shi C; Luo H; Fan L; Yang Z; Hu X; Zhang Z; Zhang S; Hu Z; Fan Y; Yang J; Mao C; Xu Y
Neuroscientist; 2021 Aug; 27(4):367-387. PubMed ID: 32729773
[TBL] [Abstract][Full Text] [Related]
27. Targeted degradation of ⍺-synuclein aggregates in Parkinson's disease using the AUTOTAC technology.
Lee J; Sung KW; Bae EJ; Yoon D; Kim D; Lee JS; Park DH; Park DY; Mun SR; Kwon SC; Kim HY; Min JO; Lee SJ; Suh YH; Kwon YT
Mol Neurodegener; 2023 Jun; 18(1):41. PubMed ID: 37355598
[TBL] [Abstract][Full Text] [Related]
28. E46K Mutant α-Synuclein Is Degraded by Both Proteasome and Macroautophagy Pathway.
Yan JQ; Yuan YH; Chu SF; Li GH; Chen NH
Molecules; 2018 Nov; 23(11):. PubMed ID: 30388770
[TBL] [Abstract][Full Text] [Related]
29. Alpha-Synuclein: The Interplay of Pathology, Neuroinflammation, and Environmental Factors in Parkinson's Disease.
He S; Zhong S; Liu G; Yang J
Neurodegener Dis; 2020; 20(2-3):55-64. PubMed ID: 33465773
[TBL] [Abstract][Full Text] [Related]
30. Cathepsin L prevents the accumulation of alpha-synuclein fibrils in the cell.
Matsuki A; Watanabe Y; Hashimoto S; Hoshino A; Matoba S
Genes Cells; 2024 Apr; 29(4):328-336. PubMed ID: 38366711
[TBL] [Abstract][Full Text] [Related]
31. Could α-synuclein amyloid-like aggregates trigger a prionic neuronal invasion?
Busquets MA; Espargaró A; Estelrich J; Sabate R
Biomed Res Int; 2015; 2015():172018. PubMed ID: 25866763
[TBL] [Abstract][Full Text] [Related]
32. Models of α-synuclein aggregation in Parkinson's disease.
Giráldez-Pérez R; Antolín-Vallespín M; Muñoz M; Sánchez-Capelo A
Acta Neuropathol Commun; 2014 Dec; 2():176. PubMed ID: 25497491
[TBL] [Abstract][Full Text] [Related]
33. Synergistic Effects of Milk-Derived Exosomes and Galactose on
Melnik BC
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33494388
[TBL] [Abstract][Full Text] [Related]
34. Posttranslational Modifications and Clearing of α-Synuclein Aggregates in Yeast.
Popova B; Kleinknecht A; Braus GH
Biomolecules; 2015 Apr; 5(2):617-34. PubMed ID: 25915624
[TBL] [Abstract][Full Text] [Related]
35. The interplay between parkin and alpha-synuclein; possible implications for the pathogenesis of Parkinson's disease.
Jęśko H; Lenkiewicz AM; Wilkaniec A; Adamczyk A
Acta Neurobiol Exp (Wars); 2019; 79(3):276-289. PubMed ID: 31587020
[TBL] [Abstract][Full Text] [Related]
36. Alterations in lysosomal and proteasomal markers in Parkinson's disease: relationship to alpha-synuclein inclusions.
Chu Y; Dodiya H; Aebischer P; Olanow CW; Kordower JH
Neurobiol Dis; 2009 Sep; 35(3):385-98. PubMed ID: 19505575
[TBL] [Abstract][Full Text] [Related]
37. alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease.
Lo Bianco C; Ridet JL; Schneider BL; Deglon N; Aebischer P
Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10813-8. PubMed ID: 12122208
[TBL] [Abstract][Full Text] [Related]
38. Molecular events underlying the cell-to-cell transmission of α-synuclein.
Choi YR; Park SJ; Park SM
FEBS J; 2021 Dec; 288(23):6593-6602. PubMed ID: 33332736
[TBL] [Abstract][Full Text] [Related]
39. The Golgi-localized, gamma ear-containing, ARF-binding (GGA) protein family alters alpha synuclein (α-syn) oligomerization and secretion.
von Einem B; Eschbach J; Kiechle M; Wahler A; Thal DR; McLean PJ; Weishaupt JH; Ludolph AC; von Arnim CAF; Danzer KM
Aging (Albany NY); 2017 Jul; 9(7):1677-1697. PubMed ID: 28722658
[TBL] [Abstract][Full Text] [Related]
40. Natural alkaloid harmine promotes degradation of alpha-synuclein via PKA-mediated ubiquitin-proteasome system activation.
Cai CZ; Zhou HF; Yuan NN; Wu MY; Lee SM; Ren JY; Su HX; Lu JJ; Chen XP; Li M; Tan JQ; Lu JH
Phytomedicine; 2019 Aug; 61():152842. PubMed ID: 31048127
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
